-
141
Essential oils from Amorpha fruticosa against hepatocellular carcinoma based on network pharmacology
Published 2025-01-01“…The objective of present study was to examine the chemical compositions of AFLEO and AFFEO, then investigate the effects and pharmacological mechanism of EOs against hepatocellular carcinoma (HCC). Methods The chemical compositions of EOs were examined using gas chromatography-mass spectrometry (GC-MS). …”
Get full text
Article -
142
DHX37 Impacts Prognosis of Hepatocellular Carcinoma and Lung Adenocarcinoma through Immune Infiltration
Published 2020-01-01“…Confirming the prognostic value of DHX37 in liver hepatocellular carcinoma (LIHC) and lung adenocarcinoma (LUAD), we explored the role of DHX37 in infiltrated lymphocytes in cancers using the Gene Expression Profiling Interactive Analysis (GEPIA) and TIMER databases. …”
Get full text
Article -
143
GDF15 induces immunosuppression via CD48 on regulatory T cells in hepatocellular carcinoma
Published 2021-09-01“…Background A better understanding of the molecular mechanisms that manifest in the immunosuppressive tumor microenvironment (TME) is crucial for developing more efficacious immunotherapies for hepatocellular carcinoma (HCC), which has a poor response to current immunotherapies. …”
Get full text
Article -
144
Comprehensive Landscape of ARID Family Members and Their Association with Prognosis and Tumor Microenvironment in Hepatocellular Carcinoma
Published 2022-01-01“…As one of the most lethal forms of cancers, hepatocellular carcinoma (HCC) claims many lives around the world, and it is especially common in China. …”
Get full text
Article -
145
Silymarin as a Therapeutic Agent for Hepatocellular Carcinoma: A Multi-Approach Computational Study
Published 2025-01-01Subjects: Get full text
Article -
146
Identification of Key Genes and Prognostic Value Analysis in Hepatocellular Carcinoma by Integrated Bioinformatics Analysis
Published 2019-01-01“…This study is aimed at identifying novel key genes that may be used for hepatocellular carcinoma (HCC) diagnosis, prognosis, and targeted therapy. …”
Get full text
Article -
147
Genome-Wide and Gene-Specific Epigenomic Platforms for Hepatocellular Carcinoma Biomarker Development Trials
Published 2014-01-01“…The majority of the epigenomic reports in hepatocellular carcinoma have focused on identifying novel differentially methylated drivers or passengers of the oncogenic process. …”
Get full text
Article -
148
SLC1A4 Promotes Malignant Transformation of Hepatocellular Carcinoma by Activating the AKT Signaling
Published 2025-01-01“…Due to the difficulty in early diagnosis and the lack of treatment for advanced disease, the mortality rate of hepatocellular carcinoma (HCC) is high, and the 5-year overall survival rate is low at present. …”
Get full text
Article -
149
Safety of Simultaneous Hepatectomy and Splenectomy in the Treatment of Hepatocellular Carcinoma Complicated with Hypersplenism: A Meta-analysis
Published 2019-01-01“…We conducted this meta-analysis to compare the efficacy and safety of simultaneous hepatectomy and splenectomy (HS) with hepatectomy alone (HA) in patients with hepatocellular carcinoma (HCC) and hypersplenism. Materials and Methods. …”
Get full text
Article -
150
Mortality Predicted Accuracy for Hepatocellular Carcinoma Patients with Hepatic Resection Using Artificial Neural Network
Published 2013-01-01“…The aim of this present study is firstly to compare significant predictors of mortality for hepatocellular carcinoma (HCC) patients undergoing resection between artificial neural network (ANN) and logistic regression (LR) models and secondly to evaluate the predictive accuracy of ANN and LR in different survival year estimation models. …”
Get full text
Article -
151
TMEM147 Correlates with Immune Infiltration and Serve as a Potential Prognostic Biomarker in Hepatocellular Carcinoma
Published 2023-01-01“…Background. Hepatocellular carcinoma (HCC) is one of the most prevalent malignancies and is associated with high mortality. …”
Get full text
Article -
152
Advanced Hepatocellular Carcinoma with Subtotal Occlusion of the Inferior Vena Cava and a Right Atrial Mass
Published 2013-01-01“…Hepatocellular carcinoma usually metastasizes to regional lymph nodes, lung, and bones but can rarely invade the inferior vena cava with intravascular extension to the right atrium. …”
Get full text
Article -
153
Machine Learning-based Prediction of HBV-related Hepatocellular Carcinoma and Detection of Key Candidate Biomarkers
Published 2022-09-01Subjects: “…hepatocellular carcinoma…”
Get full text
Article -
154
TERT-TP53 mutations: a novel biomarker pair for hepatocellular carcinoma recurrence and prognosis
Published 2025-01-01“…Abstract Hepatocellular carcinoma (HCC) is the most prevalent form of liver cancer, and ranks among the most lethal malignancies globally, primarily due to its high rates of recurrence and metastasis. …”
Get full text
Article -
155
A proton therapy model using discrete difference equations with an example of treating hepatocellular carcinoma
Published 2017-07-01Subjects: Get full text
Article -
156
Hepatic arterial infusion chemotherapy combined with systemic therapy sequentially or simultaneously for advanced hepatocellular carcinoma
Published 2024-11-01Subjects: Get full text
Article -
157
Potential diagnostic value of high b-value computed diffusion-weighted imaging in hepatocellular carcinoma
Published 2024-06-01Subjects: Get full text
Article -
158
Analysis of Extrahepatic Multiple Primary Malignancies in Patients with Hepatocellular Carcinoma according to Viral Infection Status
Published 2012-01-01“…Previous studies have investigated extrahepatic multiple primary malignancy (EHPM) associated with hepatocellular carcinoma (HCC). However, its correlation with viral infection, such as hepatitis B virus (HBV) or hepatitis C virus (HCV), has not been examined. …”
Get full text
Article -
159
PIVKA-II as a surrogate biomarker for therapeutic response in Non-AFP-secreting hepatocellular carcinoma
Published 2025-02-01Subjects: Get full text
Article -
160
Design and Mechanism Study of 6c, a Novel Artesunate Derivatives, for Anti-Hepatocellular Carcinoma
Published 2025-01-01Subjects: “…hepatocellular carcinoma…”
Get full text
Article